-
Observed outcomes by treatment arm and by the ACCORD-BP trial population’s pr...
Observed outcomes by treatment arm and by the ACCORD-BP trial population’s predicted benefit/harm (validation cohort). -
Demographic characteristics and comorbidities of HNSCC in Taiwan (n = 18243).
Demographic characteristics and comorbidities of HNSCC in Taiwan (n = 18243). -
r37980778c78--ecc0895efe03f2f06eeae815e1b0fc85
Incidence density of secondary primary cancer in aspirin users and non-aspirin users among HNSCC patients identified during 2000–2011. -
Observed outcomes by treatment arm and by benefit/harm subgroup for the SPRIN...
Observed outcomes by treatment arm and by benefit/harm subgroup for the SPRINT trial (derivation cohort) and ACCORD-BP trial (validation cohort) when applying models fit by... -
r37980778c78--0a931cd03bcbddcb42553a3fd7018d87
Baseline characteristics of the SPRINT trial participants included for model derivation (N = 9,069) and ACCORD-BP trial participants included for model validation (N = 4,498). -
Baseline characteristics of participants.
Data are presented as mean±SD, median (interquartile range) or percent. Chi-square test for categorical variables, the unpaired t test or Mann-Whitney U test for continuous... -
Rural and Urban poverty ratio for India calculated with aggregate and micro d...
Rural and Urban poverty ratio for India calculated with aggregate and micro data and the difference between the two, before and after medicine purchase. -
dedup_wf_001--8c850ab7ba1b764088d86e69b0bbbed7
Survival data collected in the experimental fields of FORBIO (http://www.treedivbelgium.ugent.be/). This includes data at the plot level for the sites Hechtel-Eksel, Zedelgem... -
r37980778c78--4d99f1ab43861f80bf04e2ea9137adfc
Comparison of discrimination and calibration for models fit by elastic net regularization versus traditional backwards selection. -
r37980778c78--56905ae4677c893a88bec378abb0acf0
Risk score for harm from intensive blood pressure treatment, developed from the SPRINT trial. -
r37980778c78--8ff1da1f0b0aaee0528980600e5ff5cf
Risk score for benefit from intensive blood pressure treatment, developed from the SPRINT trial. -
r37980778c78--b3b8923e993df371c9ab910d5cb655e9
BackgroundDuring the 2014–2016 West Africa Ebola Virus Disease (EVD) epidemic, the public health community had concerns that sexual transmission of the Ebola virus (EBOV) from... -
Poverty ratio and poverty gap index for rural and urban India before and afte...
Poverty ratio and poverty gap index for rural and urban India before and after medication purchase, calculated by using aggregate data. -
r37980778c78--22b45d53a2c4e79d33ef1a3288d469d8
Cost-effectiveness of cardiovascular medicines for primary prevention of Ischemic Heart Disease. -
Estimates of the number of people that could benefit from cardiovascular medi...
Estimates of the number of people that could benefit from cardiovascular medicines and the resulting number of people financially burdened or impoverished due to medication... -
The incidence density of secondary primary cancer in Aspirin users and Non-as...
The incidence density of secondary primary cancer in Aspirin users and Non-aspirin users among HNSCC patients stratified by follow-up duration. -
Baseline patient characteristics.
Data are presented as median (interquartile range) or number (n [%]), as appropriate. Baseline characteristics were compared between the two diagnostic groups using a... -
r37980778c78--ceca5efea0530ad16926908b9116ca30
Common drugs for cardiovascular disease prevention in the national essential medicines list and their prices. -
Ranking table for valuing risks, based on ERI index.
Ranking table for valuing risks, based on ERI index.